Market Overview:
The global radiopharmaceutical production systems market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. In addition, the increasing number of research centers and pharmaceutical companies are also contributing to the growth of this market. On the basis of type, the global radiopharmaceutical production systems market is segmented into automatic and manual systems. The automatic systems segment is expected to grow at a higher CAGR than that of manual systems during the forecast period from 2018 to 2030. This can be attributed to its advantages such as ease-of-use, accuracy, repeatability, and reduced human error rates. On the basis of application, this market is segmented into research centers, pharmaceutical companies, and others (including hospitals/clinics).
Product Definition:
Automatic:
Automatic is a term used to define equipment or process which carries out operations without human intervention. In the pharmaceutical industry, automatic processes are those that operate with no or very little manual intervention.
Manual:
The manual provides information on the general procedure for manufacturing, handling and packaging of products along with details regarding the equipment required and their location. It also contains information on quality control procedures to be followed during manufacturing operations.
Radiopharmaceutical production involves radioactive material in combination with other chemicals which are used as probes or diagnostic agents for medical diagnosis.
Application Insights:
The research centers segment dominated the global radiopharmaceutical production systems market in 2017. This can be attributed to factors such as an increase in government funding for cancer research and rising prevalence of cancer across the globe. For instance, according to WHO, around 1 in 6 women and 1 in 5 men are estimated to develop cancer during their lifetime. In 2018, around 2 million people were diagnosed with lung cancer globally while about 2.8 million died due to this disease worldwide that year alone.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The presence of major players, advanced healthcare infrastructure and high research & development (R&D) investment by pharmaceutical companies are some of the factors contributing to its large market share. In addition, increasing use in cancer treatment is expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising demand from emerging countries such as China and India due to growing medical tourism industry and improving healthcare facilities at a domestic level. Furthermore, government initiatives encouraging R&D activities are also expected boost regional market growth over the next eight years (2018-2030). For instance, ‘Make in India’ initiative undertaken by Indian Government aims at promoting manufacturing output with an emphasis on high value-added products within country which will create new opportunities for radiopharmaceutical production systems manufacturers/suppliers operating within Asia Pacific region.
Growth Factors:
- Increasing demand for radiopharmaceuticals due to rising incidence of cancer and other diseases
- Growing number of nuclear medicine centers and hospitals
- Technological advancements in radiopharmaceutical production systems
- Rising government funding for research on radiopharmaceuticals
- Increasing awareness about the benefits of radiopharmaceuticals
Scope Of The Report
Report Attributes
Report Details
Report Title
Radiopharmaceutical Production Systems Market Research Report
By Type
Automatic, Manual
By Application
Research Centers, Pharmaceutical Companies, Others
By Companies
PMB, Esco Pharma, IBA, Comecer, Trasis, Germfree, TM Isotopen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Radiopharmaceutical Production Systems Market Report Segments:
The global Radiopharmaceutical Production Systems market is segmented on the basis of:
Types
Automatic, Manual
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Centers, Pharmaceutical Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PMB
- Esco Pharma
- IBA
- Comecer
- Trasis
- Germfree
- TM Isotopen
Highlights of The Radiopharmaceutical Production Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Automatic
- Manual
- By Application:
- Research Centers
- Pharmaceutical Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radiopharmaceutical Production Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radiopharmaceutical production systems are used to produce pharmaceuticals from radioactive materials. These systems use radiation to break down the molecules in the radioactive material, which then produces a new form of medication.
Some of the major players in the radiopharmaceutical production systems market are PMB, Esco Pharma, IBA, Comecer, Trasis, Germfree, TM Isotopen.
The radiopharmaceutical production systems market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Radiopharmaceutical Production Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Radiopharmaceutical Production Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Radiopharmaceutical Production Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Radiopharmaceutical Production Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Radiopharmaceutical Production Systems Market Size & Forecast, 2020-2028
4.5.1 Radiopharmaceutical Production Systems Market Size and Y-o-Y Growth
4.5.2 Radiopharmaceutical Production Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Automatic
5.2.2 Manual
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research Centers
6.2.2 Pharmaceutical Companies
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Radiopharmaceutical Production Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Radiopharmaceutical Production Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Automatic
9.6.2 Manual
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research Centers
9.10.2 Pharmaceutical Companies
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Automatic
10.6.2 Manual
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research Centers
10.10.2 Pharmaceutical Companies
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Automatic
11.6.2 Manual
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research Centers
11.10.2 Pharmaceutical Companies
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Automatic
12.6.2 Manual
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research Centers
12.10.2 Pharmaceutical Companies
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Automatic
13.6.2 Manual
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research Centers
13.10.2 Pharmaceutical Companies
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Radiopharmaceutical Production Systems Market: Competitive Dashboard
14.2 Global Radiopharmaceutical Production Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PMB
14.3.2 Esco Pharma
14.3.3 IBA
14.3.4 Comecer
14.3.5 Trasis
14.3.6 Germfree
14.3.7 TM Isotopen
